Proscia Launches Fifth Generation of Concentriq, Bringing the Latest Advancements in AI to Pathologists and Scientists (opens original article in a new tab)

Proscia introduces the Fifth Generation of Concentriq, an AI platform designed to enhance pathology and drug discovery processes.

• Proscia launches the Fifth Generation of Concentriq, an AI platform for pathologists and scientists.
• The new version uses AI-native architecture to improve drug discovery, case review, and biomarker development.
• It aims to reduce workload for pathologists and enhance precision medicine processes.